Author:
Li Tao,Yang Li,Fu Sheng-jun,Xiao Er-long,Yuan Xuan,Lu Jian-zhong,Ma Bao-liang,Shi Ting-kai,Wang Zhi-ping
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference38 articles.
1. Siegel, R., Naishadham, D., & Jemal, A. (2013). Cancer statistics, 2013. CA: A Cancer Journal for Clinicians,
63, 11–30.
2. Parkin, D. M. (2008). The global burden of urinary bladder cancer. Scandinavian Journal of Urology and Nephrology. Supplementum,
2008, 12–20.
3. Pfost, B., Seidl, C., Autenrieth, M., Saur, D., Bruchertseifer, F., Morgenstern, A., et al. (2009). Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice. Journal of Nuclear Medicine,
50, 1700–1708.
4. Babjuk, M., Oosterlinck, W., Sylvester, R., Kaasinen, E., Bohle, A., Palou-Redorta, J., & Roupret, M. (2012). [EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update]. Actas Urologicas Espanolas,
36, 389–402. (in Spanish).
5. Lamm, D. L. (1992). Complications of bacillus Calmette-Guerin immunotherapy. Urologic Clinics of North America,
1992(19), 565–572.